Adenovirus type 5 E1A sensitizes hepatocellular carcinoma cells to gemcitabine

ASIA unversity > 醫學暨健康學院 > 生物科技學系 > 期刊論文 > Item 310904400/4641

Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/4641

Title:	Adenovirus type 5 E1A sensitizes hepatocellular carcinoma cells to gemcitabine
Authors:	Lee, W. P.;Tai, D.-I.;Tsai, S.-L.;Yeh, C.-T.;Chao, Y.;Lee, S.-D.;Mien-Chie Hung
Date:	2003-10
Issue Date:	2009-11-27 05:57:11 (UTC+0)
Publisher:	Asia University
Abstract:	Hepatocellular carcinoma (HCC) is resistant to conventional chemotherapy. A few clinical trials have shown that the cytidine analogue gemcitabine appears to have antitumor activity for HCC, but the overall survival times remain to be improved. In this study, we examined the synergistic effect of adenovirus type 5 E1A (E1A) and gemcitabine on HCC and found that E1A sensitized J5, J7, Huh7, and HepG2 HCC cells to gemcitabine. To further study the E1A-mediated chemosensitization, we established stable cell lines that expressed the E1A gene and then examined whether E1A could have proapoptotic activity while expressed in HCC cells. Our results clearly showed that E1A sensitized HCC cells to gemcitabine through induction of apoptosis. To study the underlying mechanism, we tested nuclear factor (NF)-B activity and found that NF-B was activated in HCC cells treated with gemcitabine but not in HCC cells that expressed E1A. Occurrence of apoptosis entails cleavage of poly (ADP-ribose) polymerase (PARP), a nuclear protein involved in DNA repair, genome stability, and maintenance of telomere length. Our study showed that gemcitabine enhanced PARP expression. However, E1A did not induce PARP cleavage but rather suppressed PARP expression at the transcriptional level. Further study showed that both NF-B and PARP played protective roles in the prevention of E1A+gemcitabine-induced apoptosis.
Relation:	CANCER RESEARCH 63(19):6229-6236
Appears in Collections:	[生物科技學系] 期刊論文

Files in This Item:

File	Description	Size	Format
		0Kb	Unknown	764	View/Open
310904400-4641 .doc		30Kb	Microsoft Word	788	View/Open

Loading...